Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity.
Even-Or O, Joseph A, Itskovitz-Cooper N, Samira S, Rochlin E, Eliyahu H, Goldwaser I, Balasingam S, Mann AJ, Lambkin-Williams R, Kedar E, Barenholz Y. Even-Or O, et al. Among authors: samira s. Vaccine. 2011 Mar 16;29(13):2474-86. doi: 10.1016/j.vaccine.2011.01.009. Epub 2011 Jan 18. Vaccine. 2011. PMID: 21251901
Adjuvanted influenza vaccines.
Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y. Even-Or O, et al. Among authors: samira s. Expert Rev Vaccines. 2013 Sep;12(9):1095-108. doi: 10.1586/14760584.2013.825445. Expert Rev Vaccines. 2013. PMID: 24053401 Review.
A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.
Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M, Kedar E. Babai I, et al. Among authors: samira s. Vaccine. 2001 Nov 12;20(3-4):505-15. doi: 10.1016/s0264-410x(01)00326-7. Vaccine. 2001. PMID: 11672916
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.
Lalazar G, Mizrahi M, Turgeman I, Adar T, Ben Ya'acov A, Shabat Y, Nimer A, Hemed N, Zolotarovya L, Lichtenstein Y, Lisovoder N, Samira S, Shalit I, Ellis R, Ilan Y. Lalazar G, et al. Among authors: samira s. J Clin Immunol. 2015 May;35(4):399-407. doi: 10.1007/s10875-015-0160-6. Epub 2015 Apr 17. J Clin Immunol. 2015. PMID: 25876706 Clinical Trial.
23 results